Establishment of the 1st Chinese national standard for CA6 neutralizing antibody

References

• Hubiche T, Schuffenecker I, Boralevi F, Léauté-Labèoze C, Bornebusch L, Chiaverini C, Phan A, Maruani A, Miquel J, Lafon M-E, et al. Dermatological spectrum of hand, foot and mouth disease from classical to generalized exanthema. Pediatr Infect Dis J. 2014;33(4):e92–8. doi:10.1097/INF.0000000000000120.
   PubMed Web of Science ®Google Scholar
• Logotheti M, Pogka V, Horefti E, Papadakos K, Giannaki M, Pangalis A, Sgouras D, Mentis A. Laboratory investigation and phylogenetic analysis of enteroviruses involved in an aseptic meningitis outbreak in Greece during the summer of 2007. J Clin Virol. 2009;46(3):270–74. doi:10.1016/j.jcv.2009.07.019.
   PubMed Web of Science ®Google Scholar
• Richter J, Koptides D, Tryfonos C, Christodoulou C. Molecular typing of enteroviruses associated with viral meningitis in Cyprus, 2000–2002. J Med Microbiol. 2006;55(Pt 8):1035–41. doi:10.1099/jmm.0.46447-0.
   PubMed Web of Science ®Google Scholar
• Koh WM, Bogich T, Siegel K, Jin J, Chong EY, Tan CY, Chen MIC, Horby P, Cook AR. The epidemiology of hand, foot and mouth disease in Asia: a systematic review and analysis. Pediatr Infect Dis J. 2016;35(10):e285–300. doi:10.1097/INF.0000000000001242.
   PubMed Web of Science ®Google Scholar
• National Health Commission of the People’s Republic of China. Diagnosis and treatment guideline on hand, foot and mouth disease (2018). Chin J Viral Dis. 2018;8(5):347–52. doi:10.3760/cma.j.issn.1674-2397.2018.03.001.
   Google Scholar
• Cyril CYY, Susanna KP, Patrick CYW, Kwok-Yung Y. Human enterovirus 71 epidemics: what’s next? Emerg Health Threats J. 2013;6(1):19780. doi:10.3402/ehtj.v6i0.19780.
   PubMedGoogle Scholar
• LianLian B, YiPing W, Xin Y, Miao X, ZhengLun L, Liang Z. Coxsackievirus A6- a new emerging pathogen causing hand, foot and mouth disease outbreaks worldwide. Expert Rev Anti Infect Ther. 2015;13(9):1061–71. doi:10.1586/14787210.2015.1058156.
   PubMed Web of Science ®Google Scholar
• Jinlin L, Jing Y, Fan Y, ZhiQiang W, YongFeng H, Ying X, BoPing Z, Qi J. Epidemic characteristics of hand, foot, and mouth disease in southern China, 2013: coxsackievirus A6 has emerged as the predominant causative agent. J Infect. 2014;69(3):299–303. doi:10.1016/j.jinf.2014.04.001.
   PubMed Web of Science ®Google Scholar
• Kelly F, Ilan Y, Huang J, McAdam A, Sandora TJ, Rennick M, Smole S, Rogers SL, Allan Nix W, Oberste MS, et al. Hand, foot, and mouth disease caused by coxsackievirus A6. Emerg Infect Dis. 2012;18(10):1702–04. doi:10.3201/eid1810.120813.
   PubMed Web of Science ®Google Scholar
• Fujimoto T, Iizuka S, Enomoto M, Abe K, Yamashita K, Hanaoka N, Okabe N, Yoshida H, Yasui Y, Kobayashi M, et al. Hand, foot, and mouth disease caused by coxsackievirus A6, Japan, 2011. Emerg Infect Dis. 2012;18:(2):337–39. doi:10.3201/eid1802.111147.
   PubMed Web of Science ®Google Scholar
• Blomqvist S, Klemola P, Kaijalainen S, Paananen A, Simonen M, Vuorinen T, Roivainen M. Co-circulation of coxsackieviruses A6 and A10 in hand, foot and mouth disease outbreak in Finland. J Clin Virol. 2010;48(1):49–54. doi:10.1016/j.jcv.2010.02.002.
   PubMed Web of Science ®Google Scholar
• Cabrerizo M, Tarragó D, Mu1oz-Almagro C, Del Amo E, Domínguez-Gil M, Eiros JM, López-Miragaya I, Pérez C, Reina J, Otero A, et al. Molecular epidemiology of enterovirus 71 coxsackievirus A16 and A6 associated with hand, foot and mouth disease in spain. Clin Microbiol Infect. 2014;20(3):150–56. doi:10.1111/1469-0691.12361.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC). Notes from the field: severe hand, foot, and mouth disease associated with coxsackievirus A6 – Alabama, Connecticut, California, and Nevada, November 2011–February 2012. MMWR Morb Mortal Wkly Rep. 2012;61(12):213–14. http://archpsyc.jamanetwork.com/data/Journals/JAMA/24591/jwr120146_335_335.pdf?resultClick=1.
   PubMedGoogle Scholar
• Sinclair C, Gaunt E, Simmonds P, Broomfield D, Harvala H, Wellington L, Templeton K, Willocks L, Schofield O, Harvala H. A typical hand, foot, and mouth disease associated with coxsackievirus A6 infection, Edinburgh, United Kingdom, January to February 2014. Euro Surveill. 2014;19(12):20745. doi:10.2807/1560-7917.ES2014.19.12.20745.
   PubMedGoogle Scholar
• Mirand A, le Sage FV, Pereira B, Cohen R, Levy C, Archimbaud C, Peigue-Lafeuille H, Bailly J, Henquell C. Ambulatory pediatric surveillance of hand, foot and mouth disease as signal of an outbreak of Coxsackievirus A6 infections, France, 2014–2015. Emerg Infect Dis. 2016;22(11):1884–93. doi:10.3201/eid2211.160590.
   PubMed Web of Science ®Google Scholar
• Wu Y, Yeo A, Phoon MC, Yan W, Andrea Y, Phoon MC, Tan EL. The largest outbreak of hand, foot and mouth disease in Singapore in 2008: the role of enterovirus 71 and coxsackievirus a strains. Int J Infect Dis. 2010;14(12):e1076. doi:10.1016/j.ijid.2010.07.006.
   PubMed Web of Science ®Google Scholar
• YiJen C, ShihCheng C, KuoChien T, ShinRu S, ShuLi Y, TzouYi H, Huang Y-C. Comparative genomic analysis of coxsackievirus A6 strains of different clinical disease entities. PLoS One. 2012;7(12):e52432. doi:10.1371/journal.pone.0052432.
   PubMed Web of Science ®Google Scholar
• Kanbayashi D, Kaida A, Yamamoto SP, Hirai Y, Kubo H, Fujimori R, Hakui N, Hirokawa H, Iritani N. Impact of coxsackievirus A6 emergence on hand, foot, and mouth disease epidemic in Osaka city, Japan. J Med Virol. 2017;89(12):2116–21. doi:10.1002/jmv.24905.
   PubMed Web of Science ®Google Scholar
• Jiratchaya P, Thaweesak C, Piyada L, Sumeth K, Siwanat T, Preyaporn V, Apiradee T, Yong P. Hand, foot, and mouth disease caused by coxsackievirus A6, Thailand, 2012. Emerg Infect Dis. 2013;19(4):641–43. doi:http://dx.doi.org/10.3201/eid1904.121666.
   PubMed Web of Science ®Google Scholar
• Biao D, Ying Z, Huaping X, Xiaoquan L, Chun C, Peng D, Peng H, Dahu W, Jinmei G, Lei L, et al. Circulation of Coxsackievirus A6 in hand-foot-mouth disease in Guangzhou, 2010-2012. Virol J. 2014;11(1):157. doi:10.1186/1743-422X-11-157.
   PubMedGoogle Scholar
• Xiao K, Duan L, Peng Y, Wu M, Mai G, Yan Z, Chen S, Lu Y. Epidemiologic features of enterovirus associated with hand，foot and mouth disease in 2013 and 2014 in Shenzhen, China. Sci Rep. 2019;9(1):3856. doi:10.1038/s41598-019-40402-2.
   PubMedGoogle Scholar
• Jie L, Ying S, Yiwei D, Yuxiang Y, Da H, Yuan L, Xiaoxia P, Yang Y, Fen L, Changying L, et al. Characterization of coxsackievirus A6- and enterovirus 71-associated hand foot and mouth disease in Beijing, China, from 2013 to 2015. Front Microbiol. 2016;7:391. doi:10.3389/fmicb.2016.00391.
   PubMed Web of Science ®Google Scholar
• Jie W, Jun Z, Guoliang X, Shufa Z, Yidong W, Chen Y, Wu Y. The epidemiological and clinical characteristics of hand, foot, and mouth disease in Hangzhou, China, 2016 to 2018. Clin Pediatr (Phila). 2020;59(7):656–62. doi:10.1177/0009922820910822.
   PubMed Web of Science ®Google Scholar
• Zhenjie Z, Zhaopen D, Qian W, Michael JC, Juan L, Tao L, Dong L, Weifeng S. Characterization of an inactivated whole-virus bivalent vaccine that induces balanced protective immunity against coxsackievirus A6 and A10 in mice. Vaccine. 2018;36(46):7095–104. doi:10.1016/j.vaccine.2018.09.069.
   PubMed Web of Science ®Google Scholar
• Caine EA, Fuchs J, Das SC, Partidos CD, Osorio JE. Efficacy of a trivalent hand, foot and mouth disease vaccine against enterovirus 71 and coxsackieviruses A16 and A6 in mice. Viruses. 2015;7(11):5919–32. doi:10.3390/v7112916.
   PubMed Web of Science ®Google Scholar
• Lim H, In HJ, Lee JA, Sik Yoo J, Lee SW, Chung GT, Choi YK, Chung JK, Cho SJ, Lee JW. The immunogenicity and protection effect of an inactivated coxsackievirus A6, A10, and A16 vaccine against hand, foot, and mouth disease. Vaccine. 2018;36(24):3445–52. doi:10.1016/j.vaccine.2018.05.005.
   PubMed Web of Science ®Google Scholar
• Liu CC, Guo MS, Wu SR, Lin HY, Yang YT, Liu WC, Chow YH, Shieh DB, Wang JR, Chong P. Immunological and biochemical characterizations of coxsackievirus A6 and A10 viral particles. Antiviral Res. 2016;129:58–66. doi:10.1016/j.antiviral.2016.02.008.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Shen C, Zhang C, Zhang W, Wang L, Lan K, Liu Q, Huang Z. Yeast-produced recombinant virus-like particles of coxsackievirus A6 elicited protective anti-bodies in mice. Antiviral Res. 2016;132:165–69. doi:10.1016/j.antiviral.2016.06.004.
   PubMed Web of Science ®Google Scholar
• Shen C, Ku Z, Zhou Y, Li D, Wang L, Lan K, Liu Q, Huang Z. Virus-like particle-based vaccine against coxsackievirus A6 protects mice against lethal infections. Vaccine. 2016;34(34):4025–31. doi:10.1016/j.vaccine.2016.06.028.
   PubMed Web of Science ®Google Scholar
• Zhang W, Dai W, Zhang C, Zhou Y, Xiong P, Wang S, Ye X, Liu Q, Zhou D, Huang Z. A virus-like particle-based tetravalent vaccine for hand, foot, and mouth disease elicits broad and balanced protective immunity. Emerg Microbes Infect. 2018;7(1):94. doi:10.1038/s41426-018-0094-l.
   PubMed Web of Science ®Google Scholar
• Deng H, Yu S, Guo Y, Gu L, Wang G, Ren Z, Li Y, Li K, Li R. Development of a multivalent enterovirus subunit vaccine based on immunoinformatic design principles for the prevention of HFMD. Vaccine. 2020;38(20):3671–81. doi:10.1016/j.vaccine.2020.03.023.
   PubMed Web of Science ®Google Scholar
• WHO CC. WHO collaborating center for standardization and evaluation of biologicals [accessed 2022 Oct 28]. https://www.nifdc.org.cn/nifdc/gjhz/whoshwhzzx/index.html.
   Google Scholar
• WHO. WHO manual for the preparation of reference materials for use as secondary standards in antibody testing [M/OL]. In: WHO Expert Committee on Biological Standardization: Seventy-fifth report; 2022 [accessed 2022 Oct 28]. https://www.who.int/publications/m/item/who-manual-for-reference-material-for-antibody-testing.
   Google Scholar
• WHO. Recommendations for the preparation, characterization and establishment of international and other biological reference standards [M/OL]. In: WHO Expert Committee on Biological Standardization: fifty-fifth report; 2004 [accessed 2022 Oct 28]. https://www.who.int/publications/i/item/9241209321.
   Google Scholar
• Chinese Pharmacopoeia Commisson. Pharmacopeia of the People’s Republic of China. Vol. III. Beijing: China Medical Science Press; 2020. p. 23–24.
   Google Scholar
• Tan D, Ma S. Yao pin jian du yu jian ding zhong de tong ji xue ying yong [Statistic applications in biopharmaceutical regulatory science]. Beijing: China Science and Technology Press; 2011. Chinese.
   Google Scholar
• Mao Q, Wang Y, Bian L, Xu M, Liang Z. EV-A71 vaccine licensure: a first step for multivalent enterovirus vaccine to control HFMD and other severe diseases. Emerg Microbes Infect. 2016;5(7):e75. doi:10.1038/emi.2016.73.
   PubMedGoogle Scholar
• Gao F, Mao QY, Chen P, Bian LL, Yao X, Li JX, Zhu FC, Liang ZL. Seroepidemiology of Coxsackievirus A6,Coxsackievirus A16, and Enterovirus 71 infections in infants and children a prospective cohort study in Jiangsu, China. J Infect. 2016;73(5):509–12. doi:10.1016/j.jinf.2016.08.008.
   PubMed Web of Science ®Google Scholar
• Han JF, Xu S, Zhang Y, Zhu SY, Wu DL, Yang XD, Liu H, Sun BX, Wu XY, Qin CF. Hand, foot, and mouth disease outbreak caused by coxsackievirus A6, China, 2013. J Infect. 2014;69(3):303–05. doi:10.1016/j.jinf.2014.03.015.
   PubMed Web of Science ®Google Scholar
• Lu J, Zeng H, Zheng H, Yi L, Guo X, Liu L, Sun L, Tan X, Li H, Ke C, et al. Hand, foot and mouth disease in Guangdong, China, in 2013: new trends in the continuing epidemic. Clin Microbiol Infect. 2014;20(7):O442–45. doi:10.1111/1469-0691.12468.
   PubMed Web of Science ®Google Scholar
• Hongyan G, Chengjie M, Qiaozhi Y, Wenhao H, Juan L, Lin P, Yanli X, Hongshan W, Xingwang L. Hand, foot and mouth disease caused by coxsackievirus A6, Beijing, 2013. Pediatr Infect Dis J. 2014;33(12):1302–03. doi:10.1097/INF.0000000000000467.
   PubMed Web of Science ®Google Scholar
• Li JL, Yuan J, Yang F, Wu ZQ, Hu YF, Xue Y, Zhou BP, Jin Q. Epidemic characteristics of hand, foot, and mouth disease in southern China, 2013: coxsackievirus A6 has emerged as the predominant causative agent. J Infect. 2014;69(3):299–303. doi:10.1016/j.jinf.2014.04.001.
   PubMed Web of Science ®Google Scholar
• Chen W, Weng YW, He WX, Zhang YJ, Yang XH, Meng H, Xie JF, Wang JZ, Zheng KC, Yan YS. Molecular epidemiology of HFMD-associated pathogen coxsackievirus A6 in Fujian Province, 2011–2013. Bing Du Xue Bao. 2014;30(6):624–29. doi:10.13242/j.cnki.bingduxuebao.002575.
   PubMedGoogle Scholar
• Wang J, Teng Z, Cui X, Li C, Pan H, Zheng Y, Mao S, Yang Y, Wu L, Guo X, et al. Epidemiological and serological surveillance of hand-foot-and-mouth disease in Shanghai, China, 2012–2016. Emerg Microbes Infect. 2018;7(1):8. doi:10.1038/s41426-017-0011-z.
   PubMedGoogle Scholar
• Liu XF, Sun XM, Sun XW, Yang YQ, Huang CH, Wen H. Epidemiological study on hand, foot and mouth disease in Tongzhou District, Beijing, 2013–2017. J Int Med Res. 2019;47(6):2615–25. doi:10.1177/0300060519841974.
   PubMed Web of Science ®Google Scholar
• Si-Yuan LIU, Ya-Qian HUO, Mei-Rong GU, Fan GAO, Qun-Ying MAO, Wei JIANG, Lian-Lian BIAN. Molecular epidemic characteristics of pathogen of hand, foot and mouth disease in Guangdong and Jiangsu Provinces, China from 2018 to 2019. Chin J Biol. 2021;34(2):186–91. doi:10.13200/j.cnki.cjb.003270.
   Google Scholar
• World Health Organization. Report on the WHO collaborative study to establish the 1st International Standard for anti-EV71 serum (human), [EB/OL] [accessed 2022 Oct 28]. https://www.who.int/publications/m/item/WHO-BS-2015.2267.
   Google Scholar
• World Health Organization. Report on the WHO collaborative study to establish the 1st International Standard for Enterovirus A71 inactivated vaccine, [EB/OL] [accessed 2022 Oct 28]. https://www.who.int/publications/m/item/WHO-BS-2019.2362.
   Google Scholar
• Qunying M, YiPing W, Lianlian B, Fan G, Xin Y, Zhenglun L, Miao X, Junzhi W. R&D and application of WHO international standards for enterovirus 71. Chin J Biol. 2016;29(12):1355–57. doi:10.13200/j.cnki.cjb.001569.
   Google Scholar
• Liang Z, Mao Q, Gao Q, Li X, Dong C, Yu X, Yao X, Li F, Yin W, Li Q, et al. Establishing China’s national standards of antigen content and neutralizing antibody responses for evaluation of enterovirus 71(EV71) vaccines. Vaccine. 2011;29(52):9668–74. doi:10.1016/j.vaccine.2011.10.018.
   PubMed Web of Science ®Google Scholar
• Qunying M, Fan G, Lianlian B, Bopei C, Ruixiao D, Miao X, Zhenglun L. Assignment of international unit for national enterovirus 71 neutralizing antibody standard in China. Chin J Viral Dis. 2018;8(6):469–75. doi:10.16505/j.2095-0136.2018.0099.
   Google Scholar
• Qunying M, Fan G, Zejun W, Xiuling L, Qiang G, Wenqi AN, Erxia Y, Lianlian B, Ruixiao D, Bopei C, et al. Collaborative study on calibration and applicability of national antigen standard for coxsackievirus A16 vaccine. Chin J Viral Dis. 2018;8(6):481–86. doi:10.16505/j.2095-0136.2018.0107.
   Google Scholar
• Qunying M, Lianlian B, Fan G, Ce Y, Xin Y, Yiping W, Miao X, Zhenglun L. Collaborative calibration study of national potency reference for EV71 vaccine. Prog Microbiol Immunol. 2016;44(06):19–22. doi:10.13309/j.cnki.pmi.2016.06.004.
   Google Scholar